Recently, the Ministry of Commerce, the National Development and Reform Commission, and the Ministry of Finance have jointly rolled out the Action Plan for Leveraging Foreign Investment to Foster Steady and High-Quality Development. The plan advocates for bolstering foreign investment in the high-quality growth of the pharmaceutical sector, among others. This involves delving into and formulating implementation guidelines for segmented pharmaceutical production, thereby simplifying the process for overseas pharmaceutical marketing authorization holders to engage in cross-border segmented production of biological and chemical pharmaceuticals. Additionally, the plan aims to broaden the scope of pilot regions for opening up in biotechnology and wholly foreign-owned hospitals. It supports insurers in expanding commercial insurance coverage to encompass more innovative pharmaceuticals and medical devices, consistently motivating high-quality innovative pharmaceuticals and medical devices to penetrate the Chinese market. Furthermore, the plan emphasizes the establishment of industry collaboration platforms to streamline the entry of pharmaceuticals produced by foreign-invested enterprises into retail channels.